Highlights AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 15:27:23 16/02/2026 GMT			5-day change	1st Jan Change
15,093.00 ^GBX	-0.17%		+8.77%	+9.54%

10:48am	ASTRAZENECA : Deutsche Bank maintains a Sell rating	ZD
09:54am	RBC cuts Schroders, LBBW says 'hold' Unilever	AN

Highlights

02-13	Sector Update: Health Care Stocks Higher Friday Afternoon	MT
02-13	European Equities Mixed in Friday Trading; Spain's January CPI Declines	MT
02-13	AstraZeneca Announces Positive and clinically meaningful Results from the Phase III KALOS and Logos Trials for Breztri in Patients with Undundant Ast Astrazeneca's Breztri in Patients	CI
02-13	Stocks edge lower ahead of US CPI data	AN
02-13	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform	CI
02-13	NatWest results ahead of forecasts, ups dividend 51%	AN
02-12	AbbVie sues US health agency over Botox price controls	RE
02-12	China Indicts Ex-AstraZeneca Regional Chief for Alleged Illegal Trade, Insurance Fraud	MT
02-11	China charges former AstraZeneca regional head Leon Wang	RE
02-11	UK Shares Rally Amid Corporate Earnings Spree	MT
02-11	FTSE 100 climbs, US jobs data beats expectations	AN
02-11	China charges former AstraZeneca executive Leon Wang	RE
02-11	China charges former AstraZeneca executive Leon Wang - FT	RE
02-11	Chinese Authorities Charge AstraZeneca's Ex-China Business Head	MT
02-11	AstraZeneca Forecasts Lifted as BofA Notes 'Big Pipeline' of Key Drugs Ahead	MT
02-10	AstraZeneca: Bright 2026 outlook a key takeaway
02-10	Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	MT
02-10	Sector Update: Health Care	MT
02-10	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Economic Data Deluge	MT
02-10	AstraZeneca PLC Declares Second Interim Dividend for Fiscal Year 2025, Payable on 23 March 2026	CI
02-10	AstraZeneca PLC Provides Earnings Guidance for the Fiscal Year 2026	CI
02-10	FTSE 100 slides as BP, Standard Chartered drag	RE
02-10	AstraZeneca Upbeat on Growth as 2025 Profit, Revenue Rise Amid 'Excellent' Pipeline Delivery	MT
02-10	AstraZeneca Reiterates $80 Billion Revenue Goal for 2030 -- Update	DJ
02-10	North American Morning Briefing : U.S. Futures Steady Ahead of Economic Data	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

AstraZeneca: Bright 2026 outlook a key takeaway

February 10, 2026 at 05:01 pm

AstraZeneca CFO on M&A Strategy and Obesity Market

January 13, 2026 at 10:34 pm

AstraZeneca's CEO reportedly considers listing in the United States

July 02, 2025 at 08:39 am